The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
Article usage
Posted May 19, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (672)
- Anesthesia (181)
- Cardiovascular Medicine (2662)
- Dermatology (224)
- Emergency Medicine (404)
- Epidemiology (12273)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4127)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2671)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3913)
- Nursing (211)
- Nutrition (583)
- Oncology (2055)
- Ophthalmology (590)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1117)
- Primary Care Research (456)
- Public and Global Health (6552)
- Radiology and Imaging (1411)
- Respiratory Medicine (873)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)